Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nobilis Health Corp. N.HLTH

Alternate Symbol(s):  NRTSF

Nobilis Health Corp is a full-service healthcare development and management company. It owns and operates healthcare centers and facilities and provides minimally invasive procedures to patients and also utilizes direct to patient marketing and proprietary technologies to drive patient engagement and education. The firm also provides its services to its medical facilities as well as to third parties as a stand-alone service. The company has Medical and Marketing reportable business segments and


NEO:HLTH - Post by User

Bullboard Posts
Post by BigGreenWhale01on May 02, 2017 2:01pm
221 Views
Post# 26193553

13- 3-4 Star Funds are Buying Vs. 5- 3-4 Star Funds Selling

13- 3-4 Star Funds are Buying Vs. 5- 3-4 Star Funds Selling
Names such as Blackrock, Mellon, ProShares, Schwab, Rydex, Fidelity, Royce, Sun America, Principal and Vanguard. These funds have very deeeeep pockets and when they really get onside and greater weight HLTH, the SP will move north and smoke the shorts. They're no idiots.

Any way you dissect the Qtr 1/17 results, it reveals a very positive direction for the company. I particularly liked the +400% increase in 1st Qtr revenues Y/Y. As an investor, I don't sweat the little stuff. Growth cost.. full stop.  HLTH's growth over a company.. ohhh.. let's say CRH.. is far better and the market is finally recognizing the flaws in CRH's model whom I've written earlier is far more worthy of short interest than Nobilis.

As Nobilis1 wrote earlier.. Time to move on. There's nothing cor you here anymore.
Bullboard Posts